Suchergebnisse - "Burhenne, Jürgen"

PubPharm (30)

1

Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

2

Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01) : A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial

enthalten in: The Journal of pediatrics | 2024

von Wintermark, P. | Lapointe, A. | Steinhorn, R. | +15

3

Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers

enthalten in: European journal of drug metabolism and pharmacokinetics | 2024

von Stoll, F. | Blank, A. | Mikus, G. | +7

4

Effect of Clomethiazole Vs. Clorazepate on Hepatic Fat and Serum Transaminase Activities in Alcohol-Associated Liver Disease : Results from a Randomized, Controlled Phase II Clinical Trial

enthalten in: Alcohol and alcoholism (Oxford, Oxfordshire) | 2023

von Hohmann, N. | Schröder, F. | Moreira, B. | +6

5

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

6

Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug-Drug Interaction Trial in Healthy Adults

enthalten in: Clinical pharmacology in drug development | 2022

von Stoll, F. | Blank, A. | Mikus, G. | +10

7

Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail

enthalten in: Clinical pharmacokinetics | 2022

von Rohr, B. | Foerster, K. | Blank, A. | +4

8

Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release Characteristics

enthalten in: Clinical pharmacology in drug development | 2021

von Huppertz, A. | Bollmann, J. | Behnisch, R. | +5

9

Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients

enthalten in: British journal of pharmacology | 2021

von Aklillu, E. | Zumla, A. | Habtewold, A. | +5

10

Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses

enthalten in: British journal of clinical pharmacology | 2019

von Hohmann, N. | Blank, A. | Burhenne, J. | +3